Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 1,279 results for "Medical Malpractice Law & Strategy"...

Undoing Pliva Inc. v. Mensing
November 29, 2012
This article examines the relationship between <i>Pliva</i> and the Patient Safety and Generic Labeling Improvement Act, and discusses the potential ramifications for generic drug manufacturers should the Act be signed into law.
Verdicts
October 29, 2012
Recent rulings of importance.
Med Mal News
October 29, 2012
All the latest news.
Drug & Device News
October 29, 2012
A look at what's new.
The Collateral Source Rule and State-Provided Services
October 29, 2012
As discussed last month, most states adhere to the collateral source rule to preclude defendants in med mal suits from presenting the jury with evidence that public benefits, such as state-provided special education and therapy, may be available to the plaintiff. Not all states have fallen in line with this general rule, however.
HIPAA Update
October 29, 2012
In 2012, OCR has entered into four settlement agreements with Corrective Action Plans (CAPs), more than in any year since HITECH went into effect; three of these arose from breach notifications, which had not happened before.
Drug Compounding: Many Considerations
October 29, 2012
The tug-of-war pitting patients against pharmaceutical companies against pharmacists selling competing compound drug mixtures to the public has lately gained greater urgency.
Verdicts
September 26, 2012
Analysis of a recent key ruling.
Drug & Device News
September 26, 2012
A look at a reconsidered decision.
Med Mal News
September 26, 2012
A look at a recent important decision.

MOST POPULAR STORIES

  • The FTC Gets Into the College Athlete NIL Game
    As national champions are crowned in men's and women's basketball, hundreds of thousands of college athletes are entering the influencer marketplace for the first time and now find themselves attractive candidates in the fast growing influencer marketing arena. With influencer marketing potentially providing a 5x return on investment, many brands are eager to get into the industry, but it doesn't come without risks as the FTC Commissioner is taking a closer look at the use of influencers for marketing.
    Read More ›
  • The Roadmap of Litigation Analytics
    Litigation analytics can be considered a roadmap of sorts — an important guide to ensure the legal professional arrives at the correct litigation strategy or business plan. However, like roadmaps, litigation analytics will only be useful if it's based on data that is complete and accurate.
    Read More ›